Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: in vitro studies

In the present study, we have formulated a liposomal formulation of cytotoxic agent capecitabine (CAP) to overcome its bioavailability issues. Then we have surface modified CAP loaded liposomes (CAP-LPs) with a tumour homing peptide (THP-CAP-LPs) to achieve site specific delivery to breast cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Mantosh Kumar, Pindiprolu, Sai Kiran S. S., Reddy Sanapalli, Bharat Kumar, Yele, Vidyasrilekha, Ganesh, G. N. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070003/
https://www.ncbi.nlm.nih.gov/pubmed/35528678
http://dx.doi.org/10.1039/c9ra04814f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070003/
https://www.ncbi.nlm.nih.gov/pubmed/35528678
http://dx.doi.org/10.1039/c9ra04814f

Ejemplares similares